Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
Pulmonary Pharmacology
|
October 1, 1994
Acute effects of hypoxaemia and angiotensin II in the human pulmonary vascular bed
R I Cargill, B J Lipworth
British Journal of Clinical Pharmacology
|
December 1, 1995
Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans
R I Cargill, B J Lipworth
Thorax
|
February 1, 1995
Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans
R I Cargill, B J Lipworth
Chest
|
November 1, 1996
Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects
R I Cargill, B J Lipworth
Chest
|
February 1, 1996
Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans
R I Cargill, B J Lipworth
British Journal of Clinical Pharmacology
|
July 1, 1995
The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature
R I Cargill, B J Lipworth
British Journal of Clinical Pharmacology
|
March 1, 1997
Effects of frusemide and hypoxia on the pulmonary vascular bed in man
D G Kiely, R I Cargill, B J Lipworth
Cardiovascular Research
|
January 1, 1995
Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II
R I Cargill, A D Struthers, B J Lipworth
Chest
|
October 1, 1995
Left ventricular systolic performance during acute hypoxemia
R I Cargill, D G Kiely, B J Lipworth
British Journal of Clinical Pharmacology
|
August 1, 1994
The effects of angiotensin II on circulating levels of natriuretic peptides
R I Cargill, W J Coutie, B J Lipworth
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
Pulmonary Pharmacology
|
October 1, 1994
Acute effects of hypoxaemia and angiotensin II in the human pulmonary vascular bed
R I Cargill, B J Lipworth
British Journal of Clinical Pharmacology
|
December 1, 1995
Acute effects of ANP and BNP on hypoxic pulmonary vasoconstriction in humans
R I Cargill, B J Lipworth
Thorax
|
February 1, 1995
Pulmonary vasorelaxant activity of atrial natriuretic peptide and brain natriuretic peptide in humans
R I Cargill, B J Lipworth
Chest
|
November 1, 1996
Atrial natriuretic peptide and brain natriuretic peptide in cor pulmonale. Hemodynamic and endocrine effects
R I Cargill, B J Lipworth
Chest
|
February 1, 1996
Lisinopril attenuates acute hypoxic pulmonary vasoconstriction in humans
R I Cargill, B J Lipworth
British Journal of Clinical Pharmacology
|
July 1, 1995
The role of the renin-angiotensin and natriuretic peptide systems in the pulmonary vasculature
R I Cargill, B J Lipworth
British Journal of Clinical Pharmacology
|
March 1, 1997
Effects of frusemide and hypoxia on the pulmonary vascular bed in man
D G Kiely, R I Cargill, B J Lipworth
Cardiovascular Research
|
January 1, 1995
Human C-type natriuretic peptide: effects on the haemodynamic and endocrine responses to angiotensin II
R I Cargill, A D Struthers, B J Lipworth
Chest
|
October 1, 1995
Left ventricular systolic performance during acute hypoxemia
R I Cargill, D G Kiely, B J Lipworth
British Journal of Clinical Pharmacology
|
August 1, 1994
The effects of angiotensin II on circulating levels of natriuretic peptides
R I Cargill, W J Coutie, B J Lipworth
Page
of 3